Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
22.11.21 | WISeKey International Holding Ltd: WISeKey Announces Full Year 2021 Revenue Guidance of $20 Million, an Increase of 32% as Compared to Full Year 2020 | 1.169 | WISeKey Announces
Full
Year 2021 Revenue Guidance of $20 Million, an Increase of
32% as Compared to Full
Year 2020
WISeKey's strong cash position of over $37 million as of November 19... ► Artikel lesen | ||
16.11.21 | WISeKey International Holding Ltd: WISeKey to Hold a Metaverse Holograminar during its December 13 Investor Day at the Nasdaq MarketSite in New York City | 1.311 | WISeKey to Hold a Metaverse Holograminar during its
December 13 Investor Day at the Nasdaq MarketSite in New York City
The metaverse holograminar
is scheduled for 1pm ET / 7pm CET
Investor... ► Artikel lesen | ||
15.11.21 | Addex Therapeutics Ltd: Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149 | 1.130 | Setting Up Global Expansion of Phase 2 Clinical Evaluation in Epilepsy Patients
Ad Hoc Announcement Pursuant to Art. 53 LR
Geneva, Switzerland, November 15,
2021 - Addex Therapeutics (SIX: ADXN... ► Artikel lesen | ||
04.11.21 | Addex Therapeutics Ltd: Addex Reports Q3 2021 Financial Results and Provides Corporate Update | 999 | CHF15.5M ($16.6M) of cash and cash equivalents at
September
30, 2021Cash used in Q3 2021 of CHF2.6MDipraglurant Phase 2 blepharospasm clinical trial InitiatedPhase 2b/3 dipraglurant study in... ► Artikel lesen | ||
27.10.21 | WISeKey International Holding Ltd: WISeKey to Hold an Investor Day on December 13 at Nasdaq MarketSite | 1.336 | WISeKey to Hold an Investor Day on December 13 at Nasdaq MarketSite
Announces preliminary agenda and registration details
GENEVA / New York - October 27, 2021:
Ad-Hoc announcement pursuant to... ► Artikel lesen | ||
13.10.21 | WISeKey International Holding Ltd: WISeKey Announces 9-Month 2021 Preliminary Results; Reports Revenue of $15.4 Million, a 34% Increase from 9-Month 2020 Period | 1.424 | WISeKey Announces 9-Month 2021 Preliminary Results; Reports Revenue of $15.4 Million, a 34% Increase from 9-Month 2020 Period
Strong focus on the development and commercialization of WISe.ART anNFT... ► Artikel lesen | ||
29.09.21 | Addex Therapeutics Ltd: Addex Therapeutics Initiates Phase 2 Clinical Study with Dipraglurant in Blepharospasm | 1.143 | Type of dystonia characterized by involuntary spasms of the eyelid muscles can lead to substantial visual disturbance or functional blindness
Ad Hoc Announcement Pursuant to Art. 53 LR
Geneva, Switzerland... ► Artikel lesen | ||
28.09.21 | WISeKey International Holding Ltd: WISeKey Reports H1 2021 Results | 1.534 | Price sensitive declaration
WISeKey Reports H1 2021 Results
WISeKey's revenue of $9.9 million and strong cash reserves of $38.6 million, support investment in
AIoT and the development of its... ► Artikel lesen | ||
24.09.21 | WISeKey International Holding Ltd: WISeKey Increases Investment on its NFT Platform by Accessing the Remainder of its $44 Million Convertible Notes Subscription Agreements Signed middle of the Year | 1.571 | WISeKey Increases
Investment on its NFT Platform by Accessing the Remainder of its $44 Million Convertible Notes Subscription Agreements Signed middle of the Year
Zug, Switzerland - September 24... ► Artikel lesen | ||
22.09.21 | Addex Therapeutics Ltd: CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM as Potential Treatment for CMT1A | 1.184 | Ad Hoc Announcement Pursuant to Art. 53 LR
Glenolden, PA and Geneva, Switzerland, September
22, 2021 (GLOBE NEWSWIRE)
- The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic... ► Artikel lesen | ||
08.09.21 | Swiss Life Holding AG: Swiss Life platziert erfolgreich einen Senior Green Bond in Höhe von insgesamt EUR 600 Millionen | 1.160 | Zürich, 8. September 2021
Swiss Life platziert erfolgreich einen Senior Green Bond in Höhe von insgesamt EUR 600 Millionen
Swiss Life platzierte heute erfolgreich... ► Artikel lesen | ||
08.09.21 | Compagnie Financière Richemont SA: Decisions of the Richemont Annual General Meeting | 1.390 | COMPANY ANNOUNCEMENT8 SEPTEMBER 2021
DECISIONS OF THE RICHEMONT ANNUAL GENERAL MEETING
At the Annual General Meeting of Compagnie Financière Richemont SA... ► Artikel lesen | ||
17.08.21 | WISeKey International Holding Ltd: WISeKey Releases CEO Letter to Shareholders | 1.478 | WISeKey Releases CEO Letter to Shareholders
Zug, Switzerland - August 17, 2021: Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules - WISeKey International Holding Ltd (NASDAQ: WKEY / SIX:... ► Artikel lesen | ||
17.08.21 | Swiss Life Holding AG: Swiss Life steigert im ersten Halbjahr 2021 das Fee-Ergebnis um 14% und den Betriebsgewinn um 13% | 1.270 | Zürich, 17. August 2021Ad hoc-Mitteilung gemäss Art. 53 KR
Swiss Life steigert im ersten Halbjahr 2021 das Fee-Ergebnis um 14% und den Betriebsgewinn um 13%
Swiss... ► Artikel lesen | ||
17.08.21 | Schlatter Industries AG: Schlatter Gruppe kehrt im 1. Halbjahr 2021 in die Gewinnzone zurück | 1.186 | Ad hoc-Mitteilung gem. Art.53 LR
Schlatter Gruppe kehrt im 1. Halbjahr 2021 in die Gewinnzone zurück
S c h l i e r e n, 17. August 2021.
Die Schlatter Gruppe... ► Artikel lesen | ||
05.08.21 | Compagnie Financière Richemont SA: Changes to Board of Directors and new proposals for AGM | 1.542 | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR5 AUGUST 2021
CHANGES TO BOARD OF DIRECTORSAND NEW PROPOSALS FOR THE AGM
Richemont (the "Company") announces it... ► Artikel lesen | ||
05.08.21 | Addex Therapeutics Ltd: Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update | 994 | Strong cash and cash equivalents position at
June 30, 2021 of
CHF18.1M
($19.6M)Pivotal dipraglurant PD-LID study initiatedJanssen Pharmaceuticals started Phase 2 study in epilepsy with ADX71149Dipraglurant... ► Artikel lesen | ||
02.08.21 | Addex Therapeutics Ltd: Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science | 1.151 | Geneva, Switzerland, August 2, 2021 (GLOBE NEWSWIRE)
- Ad Hoc Announcement Pursuant to Art. 53 LR
Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering... ► Artikel lesen | ||
29.07.21 | Compagnie Financière Richemont SA: Richemont's 2021 annual report now available online | 1.224 | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR29 JULY 2021
RICHEMONT'S 2021 ANNUAL REPORT NOW AVAILABLE ONLINE
Richemont announces the publication of its... ► Artikel lesen | ||
29.07.21 | Addex Therapeutics Ltd: Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric Modulators - Indivior Commits $4 Million of New Funding | 1.044 | IND enabling studies with Indivior collaboration drug candidate and separate Addex program scheduled for
2022
Geneva, Switzerland, July 29, 2021 (GLOBE NEWSWIRE)
- Ad Hoc Announcement Pursuant... ► Artikel lesen | ||
21.07.21 | Valora Holding AG: Valora Gruppe erzielt im ersten Halbjahr 2021 ein positives EBIT, bestätigt die erwartete Rückkehr zur operativen Profitabilität vor Corona und verdoppelt das Geschäft an Schweizer Tankstellen | 1.073 | Ad hoc-Mitteilung gemäss Art. 53 KR
Valora Gruppe erzielt im ersten Halbjahr 2021 ein positives EBIT, bestätigt die erwartete Rückkehr zur operativen Profitabilität vor Corona... ► Artikel lesen | ||
20.07.21 | WISeKey International Holding Ltd: WISeKey's Semiconductor Revenue in the United States Surges Despite Shortage in Semiconductor Manufacturing | 1.428 | WISeKey's
Semiconductor Revenue in the United States Surges
Despite Shortage in Semiconductor Manufacturing
U.S. IoT segment generated revenue of approximately $4.5
million in H1 2021, a... ► Artikel lesen | ||
16.07.21 | Compagnie Financière Richemont SA: Strong trading for first quarter ended 30 June 2021; Changes to Board of Directors and Senior Executive Committee | 1.805 | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR16 JULY 2021
STRONG TRADING FOR THE FIRST QUARTER ENDED 30 JUNE 2021CHANGES TO BOARD OF DIRECTORS ANDSENIOR EXECUTIVE COMMITTEE
Highlights
Compared... ► Artikel lesen | ||
15.07.21 | DKSH Holding AG: DKSH Reports Strong Half-Year 2021 Results | 1.229 | Ad hoc announcement pursuant to Art. 53 LR
DKSH Reports Strong Half-Year 2021 Results
DKSH returns to growth with net sales reaching CHF 5.5 billion (+5.3%)¹Consistent... ► Artikel lesen | ||
14.07.21 | Compagnie Financière Richemont SA: Richemont publishes FY21 Sustainability report | 1.301 | COMPANY ANNOUNCEMENT14 JULY 2021
RICHEMONT PUBLISHES FY21 SUSTAINABILITY REPORT
Richemont announces the publication of its sustainability report for the... ► Artikel lesen |